Sign In
Buy AXSM
$233.49
+11.33 (+5.10%)
At Close: Jun 03, 2026
Missed Out On Axsome Therapeutics? My Best Biotech Stock to Buy and Hold
06:00am, Wednesday, 12'th Oct 2022
Vertex already generates billions in revenue -- but there may be more to come.
Axsome Therapeutics Voices its Commitment to Mental Health on World Mental Health Day 2022
11:00am, Monday, 10'th Oct 2022 GlobeNewswire Inc.
NEW YORK, Oct. 10, 2022 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous syst
Better Buy: Moderna vs. Axsome Therapeutics
10:00am, Monday, 10'th Oct 2022 The Motley Fool
Both of these biotechs offer exciting future prospects.
These 7 Biotech Stocks Are Set to Boom in 2023
06:15am, Monday, 10'th Oct 2022
Among biotech stocks, there are several established names that have products in markets and deep pipelines. These companies deliver predictable revenue and earnings, and maybe even a dividend for good
Better Buy: Moderna vs. Axsome Therapeutics
06:00am, Monday, 10'th Oct 2022
Both of these biotechs offer exciting future prospects.
If You Invested $5,000 in Axsome Therapeutics in 2019, This Is How Much You Would Have Today
10:30am, Saturday, 08'th Oct 2022 The Motley Fool
Could the stock keep performing?
Acadia (ACAD) Rises More Than 14% in 3 Months: Here's Why
05:36pm, Thursday, 06'th Oct 2022 Zacks Investment Research
Acadia's (ACAD) Nuplazid, approved for treating hallucinations and delusions associated with Parkinson's disease psychosis, is driving revenues. Other candidates are also making good progress.
3 Stocks Savvy Investors Are Buying Hand Over Fist
09:27am, Thursday, 06'th Oct 2022 The Motley Fool
These high-flying stocks are defying the bear market.
Axsome Therapeutics: Clear Path Ahead For AXS07
05:15pm, Wednesday, 05'th Oct 2022
Despite the recent downtrend in its trading, Axsome Therapeutics, Inc.'s fundamentals are stronger than ever. Asides from the Sunosi acquisition, the company recently gained Auvelity approval to treat
3 Healthcare Stocks That Could Make You Richer
10:30am, Wednesday, 05'th Oct 2022 The Motley Fool
It's all about much-needed products.
3 Healthcare Stocks That Could Make You Richer
06:30am, Wednesday, 05'th Oct 2022
It's all about much-needed products.
Axsome Therapeutics (AXSM) Gains But Lags Market: What You Should Know
10:00pm, Monday, 03'rd Oct 2022 Zacks Investment Research
Axsome Therapeutics (AXSM) closed at $45.33 in the latest trading session, marking a +1.59% move from the prior day.
Axsome Therapeutics Announces Sunosi® (Solriamfetol) Meets Primary Endpoint Demonstrating Improvement in Cognitive Function in the SHARP Trial in Cognitively Impaired Patients with Excessive Daytime Sleepiness Associated with Obstructive Sleep Apnea
10:30am, Monday, 03'rd Oct 2022 GlobeNewswire Inc.
Statistically significant improvement in cognitive function, as measured by the DSST RBANS compared to placebo (p=0.009, primary endpoint)
Axsome Therapeutics (AXSM) Gains As Market Dips: What You Should Know
10:15pm, Friday, 30'th Sep 2022 Zacks Investment Research
Axsome Therapeutics (AXSM) closed the most recent trading day at $44.62, moving +1.06% from the previous trading session.
8 Analysts Have This to Say About Axsome Therapeutics
02:37pm, Friday, 30'th Sep 2022 Benzinga
Analysts have provided the following ratings for Axsome Therapeutics (NASDAQ:AXSM) within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
3
1
4
0
